Somai Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Somai Pharmaceuticals's estimated annual revenue is currently $10.6M per year.
- Somai Pharmaceuticals's estimated revenue per employee is $216,000
Employee Data
- Somai Pharmaceuticals has 49 Employees.
- Somai Pharmaceuticals grew their employee count by 53% last year.
Somai Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Operating Officer / CO-Founder | Reveal Email/Phone |
Somai Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $139.1M | 412 | 0% | N/A | N/A |
#2 | $7.1M | 33 | -40% | N/A | N/A |
#3 | $47.6M | 164 | 20% | $20M | N/A |
#4 | $30.8M | 114 | -6% | $15.6M | N/A |
#5 | $10.1M | 49 | 0% | $37M | N/A |
#6 | $37.3M | 138 | -3% | N/A | N/A |
#7 | $161.5M | 471 | 7% | $156.1M | N/A |
#8 | $0.7M | 12 | -37% | $8.2M | N/A |
#9 | $63M | 244 | -6% | $385M | N/A |
#10 | $10.1M | 49 | 0% | $175.5M | N/A |
What Is Somai Pharmaceuticals?
SOMAI's quality starts from the ground up and we pride our self on only sourcing our top tier medical cannabis from select EU cultivators. Somai Pharmaceuticals places a special emphasis on scientific pharmacology expertise and experience in the field of medical Cannabis. Our teams of cultivators and scientists concentrate on the delivery of Cannabiniod treatments to the Endocannabinoid system.
keywords:N/A
N/A
Total Funding
49
Number of Employees
$10.6M
Revenue (est)
53%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Somai Pharmaceuticals News
2022-03-30 - How to Invest in Marijuana
... metrics for multistate operators are far below any growth industry average today, says Michael Sassano, CEO of Somai Pharmaceuticals.
Other Companies in Dublin
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.6M | 49 | 11% | N/A |
#2 | $7.5M | 49 | 4% | N/A |
#3 | $8.2M | 49 | -6% | N/A |
#4 | $10.6M | 49 | 4% | N/A |
#5 | $5.7M | 49 | 23% | N/A |